The reagent is used to quantitatively detect the content of microalbumin (MAU) in human urine in vitro, and is mainly used for the auxiliary diagnosis of kidney disease in clinic
Applicable to various sample types of urine
Rapid detection of single reagent (10 minutes)
Convenient storage and transportation at room temperature
Acute kidney injury (AKI) refers to the abnormality of kidney structure and function (including abnormal blood, urine, histology and imaging examination) within 3 months of disease course. resulting in clinical syndromes with different clinical manifestations.
In recent years, some new and more sensitive biomarkers of AKI have been discovered in clinical and laboratory studies, which can not only diagnose AKI before serum creatinine rises, but also provide help for the etiological diagnosis of AKI.
NGAL The best index for early diagnosis of acute kidney injury
CYS-C The best endogenous index of glomerular filtration rate
β2-MG Monitoring indicators of proximal tubule function
MAU Sensitive indicator of early or mild kidney injury
MAU is the most sensitive and reliable diagnostic indicator for early detection of renal disease. When the kidney is damaged, the urinary albumin excretion rate exceeds the normal range, which reflects the damage of glomerular filtration function and renal tubular reabsorption function. Combined with the incidence, symptoms and medical history statement, it can be more accurate to diagnose the condition.
- Important indicators for early diagnosis of hypertension and diabetic nephropathy
- Early indications of changes in the kidneys and cardiovascular system
- Auxiliary diagnosis for glomerular injury
- Surveillance of pregnancy-induced hypertensive kidney injury
Nephrology, emergency, interventional, ICU, cardiology, surgery
|Report time||10 min|
|Storage||4-30℃, sealed and kept away from light and dry|
|Validity period||18 months|
|Specifications||25 tests/box, 50 tests/box|